Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Effect of the Sequential Inoculation of Non-Saccharomyces/Saccharomyces on the Anthocyans and Stilbenes Composition of Tempranillo Wines.

Escribano-Viana R, Portu J, Garijo P, López R, Santamaría P, López-Alfaro I, Gutiérrez AR, González-Arenzana L.

Front Microbiol. 2019 Apr 9;10:773. doi: 10.3389/fmicb.2019.00773. eCollection 2019.

2.

Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients.

Merchante N, Figueruela B, Rodríguez-Fernández M, Rodríguez-Arrondo F, Revollo B, Ibarra S, Galindo MJ, Merino E, Montero M, Téllez F, García-Deltoro M, Rivero-Juárez A, Delgado-Fernández M, Ríos-Villegas MJ, Aguirrebengoa K, García MA, Portu J, Vera-Méndez FJ, Villalobos M, Mínguez C, De Los Santos I, López-Ruz MA, Omar M, Galera C, Macias J, Pineda JA; GEHEP-002 Study Group.

AIDS. 2019 Feb 1;33(2):269-278. doi: 10.1097/QAD.0000000000002065.

PMID:
30325782
3.

Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort.

Pelchen-Matthews A, Ryom L, Borges ÁH, Edwards S, Duvivier C, Stephan C, Sambatakou H, Maciejewska K, Portu JJ, Weber J, Degen O, Calmy A, Reikvam DH, Jevtovic D, Wiese L, Smidt J, Smiatacz T, Hassoun G, Kuznetsova A, Clotet B, Lundgren J, Mocroft A; EuroSIDA study.

AIDS. 2018 Oct 23;32(16):2405-2416. doi: 10.1097/QAD.0000000000001967.

PMID:
30134296
4.

Wine aroma evolution throughout alcoholic fermentation sequentially inoculated with non- Saccharomyces/Saccharomyces yeasts.

Escribano-Viana R, González-Arenzana L, Portu J, Garijo P, López-Alfaro I, López R, Santamaría P, Gutiérrez AR.

Food Res Int. 2018 Oct;112:17-24. doi: 10.1016/j.foodres.2018.06.018. Epub 2018 Jun 7.

PMID:
30131125
5.

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients.

Merchante N, Rodríguez-Arrondo F, Revollo B, Merino E, Ibarra S, Galindo MJ, Montero M, García-Deltoro M, Rivero-Juárez A, Téllez F, Delgado-Fernández M, Ríos-Villegas MJ, García MA, Vera-Méndez FJ, Ojeda-Burgos G, López-Ruz MA, Metola L, Omar M, Alemán-Valls MR, Aguirrebengoa K, Portu J, Raffo M, Macías J, Pineda JA; GEHEP-002 Study Group.

AIDS. 2018 Jul 17;32(11):1423-1430. doi: 10.1097/QAD.0000000000001809.

PMID:
29596108
6.

Evaluating a preventive biological control agent applied on grapevines against Botrytis cinerea and its influence on winemaking.

Escribano-Viana R, Portu J, Garijo P, Gutiérrez AR, Santamaría P, López-Alfaro I, López R, González-Arenzana L.

J Sci Food Agric. 2018 Sep;98(12):4517-4526. doi: 10.1002/jsfa.8977. Epub 2018 Apr 30.

PMID:
29479822
7.

Wine aromatic compound production and fermentative behaviour within different non-Saccharomyces species and clones.

Escribano R, González-Arenzana L, Portu J, Garijo P, López-Alfaro I, López R, Santamaría P, Gutiérrez AR.

J Appl Microbiol. 2018 Jun;124(6):1521-1531. doi: 10.1111/jam.13735. Epub 2018 Mar 13.

PMID:
29457321
8.

Microbial inactivation and MLF performances of Tempranillo Rioja wines treated with PEF after alcoholic fermentation.

González-Arenzana L, López-Alfaro I, Garde-Cerdán T, Portu J, López R, Santamaría P.

Int J Food Microbiol. 2018 Mar 23;269:19-26. doi: 10.1016/j.ijfoodmicro.2018.01.008. Epub 2018 Jan 9.

PMID:
29358132
9.

Impact of phenylalanine and urea applications to Tempranillo and Monastrell vineyards on grape amino acid content during two consecutive vintages.

Garde-Cerdán T, Gutiérrez-Gamboa G, Portu J, Fernández-Fernández JI, Gil-Muñoz R.

Food Res Int. 2017 Dec;102:451-457. doi: 10.1016/j.foodres.2017.09.023. Epub 2017 Sep 9.

PMID:
29195972
10.

Effects of a combination of elicitation and precursor feeding on grape amino acid composition through foliar applications to Garnacha vineyard.

Gutiérrez-Gamboa G, Portu J, López R, Santamaría P, Garde-Cerdán T.

Food Chem. 2018 Apr 1;244:159-163. doi: 10.1016/j.foodchem.2017.10.067. Epub 2017 Oct 12.

PMID:
29120764
11.

Elicitor and nitrogen applications to Garnacha, Graciano and Tempranillo vines: effect on grape amino acid composition.

Gutiérrez-Gamboa G, Portu J, López R, Santamaría P, Garde-Cerdán T.

J Sci Food Agric. 2018 Apr;98(6):2341-2349. doi: 10.1002/jsfa.8725. Epub 2017 Nov 14.

PMID:
28991367
12.

Evaluation of Grenache, Graciano and Tempranillo grape stilbene content after field applications of elicitors and nitrogen compounds.

Portu J, López R, Ewald P, Santamaría P, Winterhalter P, Garde-Cerdán T.

J Sci Food Agric. 2018 Mar;98(5):1856-1862. doi: 10.1002/jsfa.8662. Epub 2017 Oct 12.

PMID:
28885695
13.

Effects on grape amino acid concentration through foliar application of three different elicitors.

Gutiérrez-Gamboa G, Portu J, Santamaría P, López R, Garde-Cerdán T.

Food Res Int. 2017 Sep;99(Pt 1):688-692. doi: 10.1016/j.foodres.2017.06.022. Epub 2017 Jun 22.

PMID:
28784532
14.

Elicitation with methyl jasmonate supported by precursor feeding with phenylalanine: Effect on Garnacha grape phenolic content.

Portu J, López R, Santamaría P, Garde-Cerdán T.

Food Chem. 2017 Dec 15;237:416-422. doi: 10.1016/j.foodchem.2017.05.126. Epub 2017 May 25.

PMID:
28764015
15.

A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients.

Rodríguez Arrondo F, von Wichmann MÁ, Camino X, Goenaga MÁ, Ibarguren M, Azcune H, Bustinduy MJ, Ferrero O, Muñoz J, Ibarra S, Aguirrebengoa K, Goicoetxea J, Bereciartua E, Montejo M, García MA, Martínez E, Portu J, Metola L, Silvariño R, Sarasqueta C, Arrizabalaga J, Iribarren JA; (Grupo SEINORTE).

Med Clin (Barc). 2018 Apr 23;150(8):291-296. doi: 10.1016/j.medcli.2017.03.032. Epub 2017 May 18. English, Spanish.

PMID:
28528797
16.

Foliar nitrogen application in Cabernet Sauvignon vines: Effects on wine flavonoid and amino acid content.

Gutiérrez-Gamboa G, Garde-Cerdán T, Portu J, Moreno-Simunovic Y, Martínez-Gil AM.

Food Res Int. 2017 Jun;96:46-53. doi: 10.1016/j.foodres.2017.03.025. Epub 2017 Mar 12.

PMID:
28528107
17.

Phenylalanine and urea foliar application: Effect on grape and must microbiota.

González-Arenzana L, Portu J, López R, Garijo P, Garde-Cerdán T, López-Alfaro I.

Int J Food Microbiol. 2017 Mar 20;245:88-97. doi: 10.1016/j.ijfoodmicro.2017.01.017. Epub 2017 Jan 26.

PMID:
28157582
18.

Effect of methyl jasmonate application to grapevine leaves on grape amino acid content.

Garde-Cerdán T, Portu J, López R, Santamaría P.

Food Chem. 2016 Jul 15;203:536-539. doi: 10.1016/j.foodchem.2016.02.049. Epub 2016 Feb 9.

PMID:
26948648
19.

Improvement of grape and wine phenolic content by foliar application to grapevine of three different elicitors: Methyl jasmonate, chitosan, and yeast extract.

Portu J, López R, Baroja E, Santamaría P, Garde-Cerdán T.

Food Chem. 2016 Jun 15;201:213-21. doi: 10.1016/j.foodchem.2016.01.086. Epub 2016 Jan 21.

PMID:
26868568
20.

Changes on grape phenolic composition induced by grapevine foliar applications of phenylalanine and urea.

Portu J, López-Alfaro I, Gómez-Alonso S, López R, Garde-Cerdán T.

Food Chem. 2015 Aug 1;180:171-180. doi: 10.1016/j.foodchem.2015.02.042. Epub 2015 Feb 16.

PMID:
25766815
21.

Phenylalanine and urea foliar applications to grapevine: effect on wine phenolic content.

Portu J, González-Arenzana L, Hermosín-Gutiérrez I, Santamaría P, Garde-Cerdán T.

Food Chem. 2015 Aug 1;180:55-63. doi: 10.1016/j.foodchem.2015.02.008. Epub 2015 Feb 11.

PMID:
25766801
22.

Methyl jasmonate foliar application to Tempranillo vineyard improved grape and wine phenolic content.

Portu J, Santamaría P, López-Alfaro I, López R, Garde-Cerdán T.

J Agric Food Chem. 2015 Mar 4;63(8):2328-37. doi: 10.1021/jf5060672. Epub 2015 Feb 23.

PMID:
25672964
23.

Study of the effects of proline, phenylalanine, and urea foliar application to Tempranillo vineyards on grape amino acid content. Comparison with commercial nitrogen fertilisers.

Garde-Cerdán T, López R, Portu J, González-Arenzana L, López-Alfaro I, Santamaría P.

Food Chem. 2014 Nov 15;163:136-41. doi: 10.1016/j.foodchem.2014.04.101. Epub 2014 May 9.

PMID:
24912708
24.

Molecular analysis of Oenococcus oeni and the relationships among and between commercial and autochthonous strains.

González-Arenzana L, López R, Portu J, Santamaría P, Garde-Cerdán T, López-Alfaro I.

J Biosci Bioeng. 2014 Sep;118(3):272-6. doi: 10.1016/j.jbiosc.2014.02.013. Epub 2014 Mar 26.

PMID:
24680282
25.

Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial.

Labarga P, Barreiro P, da Silva A, Guardiola JM, Rubio R, Aguirrebengoa K, Miralles P, Portu J, Téllez MJ, Morano L, Castro A, Pineda JA, Terrón A, Hernández-Quero J, Mariño A, Ríos MJ, Echeverría S, Asensi V, Vispo E, Soriano V; PERICO Study Group.

J Infect Dis. 2012 Sep 15;206(6):961-8. Epub 2012 Jul 17.

PMID:
22807523
26.

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

Rallón NI, Morello J, Labarga P, Benito JM, Rodríguez-Nóvoa S, Vispo E, Barreiro P, Castro MÁ, Aguirrebengoa K, Pineda JA, Miralles P, Tellez MJ, Portu J, Miralles C, Ocampo A, Soriano V; Peginterferon Ribavirin Coinfection Team.

Clin Infect Dis. 2011 Dec;53(12):1291-5. doi: 10.1093/cid/cir665. Epub 2011 Oct 25.

PMID:
22028438
27.

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain.

Diaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

BMC Infect Dis. 2010 Sep 14;10:267. doi: 10.1186/1471-2334-10-267.

28.

Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C.

Vispo E, Labarga P, Guardiola JM, Barreiro P, Miralles C, Rubio R, Miralles P, Aguirrebengoa K, Portu J, Morello J, Rodriguez-Novoa S, Soriano V; PERICO Study Group.

AIDS Res Hum Retroviruses. 2010 Apr;26(4):419-24. doi: 10.1089/aid.2009.0120.

PMID:
20377423
29.

Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine.

Rodríguez-Arrondo F, Aguirrebengoa K, Portu J, Muñoz J, García MA, Goikoetxea J, Martínez E, Iribarren JA, Perez-Alvarez N, Negredo E, Clotet B.

Curr HIV Res. 2009 Sep;7(5):526-32.

PMID:
19925403
30.

Nephrogenic systemic fibrosis in a patient with a p-ANCA systemic vasculitis.

Cuende E, Aldamiz M, Portu J, Ruiz de Gauna R, Zaballa R, Carlos Vesga J.

Reumatol Clin. 2009 Nov-Dec;5(6):264-7. doi: 10.1016/j.reuma.2008.11.015. Epub 2009 Mar 26.

31.

[Factors related to non-prescription of tuberculin skin testing in a cohort of HIV-infected people].

Díaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

Enferm Infecc Microbiol Clin. 2010 Apr;28(4):215-21. doi: 10.1016/j.eimc.2009.06.008. Epub 2009 Aug 15. Spanish.

PMID:
19683364
32.

[Diabetes mellitus during interferon therapy].

Tarabini-Castellani P, Apraiz L, Portu J, Agud JM.

Enferm Infecc Microbiol Clin. 2008 Feb;26(2):120-1. Spanish. No abstract available.

PMID:
18341927
33.

Rickettsia monacensis and human disease, Spain.

Jado I, Oteo JA, Aldámiz M, Gil H, Escudero R, Ibarra V, Portu J, Portillo A, Lezaun MJ, García-Amil C, Rodríguez-Moreno I, Anda P.

Emerg Infect Dis. 2007 Sep;13(9):1405-7. doi: 10.3201/eid1309.060186.

34.

Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.

Martin-Carbonero L, Nuñez M, Mariño A, Alcocer F, Bonet L, García-Samaniego J, López-Serrano P, Cordero M, Portu J, Soriano V.

AIDS. 2008 Jan 2;22(1):15-21.

PMID:
18090387
35.

Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in Spain.

Diez M, Diaz A, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaria JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

Int J Tuberc Lung Dis. 2007 Nov;11(11):1196-202.

PMID:
17958981
36.

Treatment of chronic he1patitis C genotype 1 with peginterferon-alpha2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate.

Diago M, Olveira A, Solá R, Romero-Gómez M, Moreno-Otero R, Pérez R, Salmerón J, Enríquez J, Planas R, Gavilán JC, Del Olmo J, Uribarrena R, Sillero C, Benítez A, Sánchez-Galdón S, Dalmau B, Eraña L, Montoro M, Portu J, Garijo JM, Barniol R, Domínguez A, Rota R, Olcoz JL, Antón M, Pamplona X, Casanovas T, Jiménez E, Huarte M, Díaz F, Sánchez-Ruano J, Orive M, Muñoz-Sánchez M, Roset M.

Aliment Pharmacol Ther. 2007 Apr 15;25(8):899-906.

37.

[Epidemiological characteristics of new HIV infections compared with AIDS cases. The HIV/AIDS epidemic in the Basque Country].

Zulaika D, Agirrebengoa K, Andía A, Arrizabalaga J, Bustillo JM, Cámara MM, Corral J, Orive MC, Goikoetxea J, Iribarren JA, López de Munain J, Lorenzo JM, Martín Gudino MJ, Martínez E, Mayo J, Portu J, Rodríguez FJ, Silvariño R, Zubero Z.

Gac Sanit. 2004 Mar-Apr;18(2):145-9. Spanish.

38.

Effectiveness of chlorine washing disinfection and effects on the appearance of artichoke and borage.

Sanz S, Giménez M, Olarte C, Lomas C, Portu J.

J Appl Microbiol. 2002;93(6):986-93.

39.

Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.

Portu JJ, Aldamiz-Etxebarria M, Agud JM, Arévalo JM, Almaraz MJ, Ayensa C.

Addict Biol. 2002 Apr;7(2):235-41.

PMID:
12006219
40.

Value of limited necropsy in HIV-positive patients.

Guerra I, Ortiz E, Portu J, Atarés B, Aldamiz-Etxebarría M, De Pablos M.

Pathol Res Pract. 2001;197(3):165-8.

PMID:
11314779
41.

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.

Casado JL, Arrizabalaga J, Montes M, Martí-Belda P, Tural C, Pinilla J, Gutierrez C, Portu J, Schuurman R, Aguirrebengoa K.

AIDS. 1999 Aug 20;13(12):1497-502.

PMID:
10465073
42.

Institutionwide pain management improvement through the use of evidence-based content, strategies, resources, and outcomes.

Miller EH, Belgrade MJ, Cook M, Portu JB, Shepherd M, Sierzant T, Sallmen P, Fraki S.

Qual Manag Health Care. 1999 Winter;7(2):28-40.

PMID:
10346460
43.

Poncet's disease and papulonecrotic tuberculid in a patient infected with the human immunodeficiency virus.

Cuende E, Almeida V, Portu J, Aldamiz M, Erdozain MA, Vesga JC, Saracibar N.

Arthritis Rheum. 1998 Oct;41(10):1884-8.

PMID:
9778231
44.

[Constitutional syndrome, fever, and pulmonary infiltrates in the left upper lobe].

Rubio AM, Portu J, Aldamiz-Echevarría M, Erdozain MA, Jiménez C, Agud JM.

Enferm Infecc Microbiol Clin. 1997 Apr;15(4):221-2. Spanish. No abstract available.

PMID:
9312283
45.

Atypical scabies in HIV-positive patients.

Portu JJ, Santamaria JM, Zubero Z, Almeida-Llamas MV, Aldamiz-Etxebarria San Sebastian M, Gutiérrez AR.

J Am Acad Dermatol. 1996 May;34(5 Pt 2):915-7.

PMID:
8621828
46.

[Tuberculin test in HIV infection].

Portu JJ, Pérez JR, Arévalo JM, Aldamiz-Etxebarria M, Agud JM, Ayensa C.

Enferm Infecc Microbiol Clin. 1996 Feb;14(2):90-5. Spanish.

PMID:
8714155
47.

[Hemolytic anemia caused by CMV in an immunocompetent patient].

Araiz M, Menchaca C, Guinea JM, Portu JM, Pérez Clausell C.

Sangre (Barc). 1993 Oct;38(5):413. Spanish. No abstract available.

PMID:
8140507

Supplemental Content

Support Center